Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients. by Michele Angelo Colombo (22446342)

Study group background characteristics. by Zicheng Hu (3825313)

“…This relationship changed markedly with the development of <b><i>HAD</i></b> and the underlying direct neuropathic parenchymal CNS infection, i.e., <b><i>HIVE</i></b>, in which the CSF HIV-1 RNA concentrations reached high levels, and the differences between it and the blood viral load decreased. …”

Image 3_Impact of HCV cure on systemic inflammation and bone density, quality, and turnover.pdf by Christina K. Psomas (15374521)

Image 2_Impact of HCV cure on systemic inflammation and bone density, quality, and turnover.pdf by Christina K. Psomas (15374521)

Image 1_Impact of HCV cure on systemic inflammation and bone density, quality, and turnover.pdf by Christina K. Psomas (15374521)

Image 4_Impact of HCV cure on systemic inflammation and bone density, quality, and turnover.pdf by Christina K. Psomas (15374521)

Table 1_Impact of HCV cure on systemic inflammation and bone density, quality, and turnover.pdf by Christina K. Psomas (15374521)

Image 1_Insights from DCE-MRI: blood–brain barrier permeability in the context of MS relapses and methylprednisolone treatment.tiff by Stig P. Cramer (20908724)

Data Sheet 1_Insights from DCE-MRI: blood–brain barrier permeability in the context of MS relapses and methylprednisolone treatment.pdf by Stig P. Cramer (20908724)

<b>Spirulina platensis Supplementation in Obese Sedentary Women: Effects on Hematological Parameters, Metabolic Biomarkers, and Dietary Correlations</b> (Supp. Figures). by Luis Carlos Gonçalves (13153701)

“…In vivo, spirulina supplementation (3g/day) induced significant hematological modulation, characterized by a marked decrease in lymphocyte percentage (p=0.002) and a concurrent increase in segmented neutrophils (p=0.003). …”

Data Sheet 2_Insights from DCE-MRI: blood–brain barrier permeability in the context of MS relapses and methylprednisolone treatment.pdf by Stig P. Cramer (20908724)